IGF1 and colorectal carcinoma: The administration of IGF-1 to cultured CRC cells (MC-38, HCT116 and DLD-1) resulted in increased cell migration, which was inhibited by the use of the inhibitor of IGF-1R signaling, i.e., NT157.